Green nanotech paradigm for enhancing sesquiterpene lactone therapeutics in cancer
Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved..
In the field of cancer therapy, sesquiterpene lactones (SLs) derived from diverse Dicoma species demonstrate noteworthy bioactivity. However, the translation of their full therapeutic potential into clinical applications encounters significant challenges, primarily related to solubility, bioavailability, and precise drug targeting. Despite these obstacles, our comprehensive review introduces an innovative paradigm shift that integrates the inherent therapeutic properties of SLs with the principles of green nanotechnology. To overcome issues of solubility, bioavailability, and targeted drug delivery, eco-friendly strategies are proposed for synthesizing nanocarriers. Green nanotechnology has emerged as a focal point in addressing environmental and health concerns linked to conventional treatments. This progressive approach of green nanotechnology holds promise for the development of safe and sustainable nanomaterials, particularly in the field of drug delivery. This groundbreaking methodology signifies a pioneering advancement in the creation of novel and effective anticancer therapeutics. It holds substantial potential for transforming cancer treatment and advancing the landscape of natural product research.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
---|---|
Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 173(2024) vom: 26. März, Seite 116426 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zahra, Mehak [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anticancer therapy |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biopha.2024.116426 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369609921 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369609921 | ||
003 | DE-627 | ||
005 | 20240328000131.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biopha.2024.116426 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM369609921 | ||
035 | |a (NLM)38471274 | ||
035 | |a (PII)S0753-3322(24)00310-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zahra, Mehak |e verfasserin |4 aut | |
245 | 1 | 0 | |a Green nanotech paradigm for enhancing sesquiterpene lactone therapeutics in cancer |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved. | ||
520 | |a In the field of cancer therapy, sesquiterpene lactones (SLs) derived from diverse Dicoma species demonstrate noteworthy bioactivity. However, the translation of their full therapeutic potential into clinical applications encounters significant challenges, primarily related to solubility, bioavailability, and precise drug targeting. Despite these obstacles, our comprehensive review introduces an innovative paradigm shift that integrates the inherent therapeutic properties of SLs with the principles of green nanotechnology. To overcome issues of solubility, bioavailability, and targeted drug delivery, eco-friendly strategies are proposed for synthesizing nanocarriers. Green nanotechnology has emerged as a focal point in addressing environmental and health concerns linked to conventional treatments. This progressive approach of green nanotechnology holds promise for the development of safe and sustainable nanomaterials, particularly in the field of drug delivery. This groundbreaking methodology signifies a pioneering advancement in the creation of novel and effective anticancer therapeutics. It holds substantial potential for transforming cancer treatment and advancing the landscape of natural product research | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Anticancer therapy | |
650 | 4 | |a Bioactive compounds | |
650 | 4 | |a Dicoma species | |
650 | 4 | |a Green nanotechnology | |
650 | 4 | |a Sesquiterpene lactones | |
650 | 7 | |a Sesquiterpenes |2 NLM | |
650 | 7 | |a Lactones |2 NLM | |
700 | 1 | |a Abrahamse, Heidi |e verfasserin |4 aut | |
700 | 1 | |a George, Blassan P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 173(2024) vom: 26. März, Seite 116426 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
773 | 1 | 8 | |g volume:173 |g year:2024 |g day:26 |g month:03 |g pages:116426 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2024.116426 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 173 |j 2024 |b 26 |c 03 |h 116426 |